India's Sun Pharmaceutical intends to be the white knight that will turn around manufacturing problems at Ranbaxy Laboratories once it finalizes its $3.2 billion buyout of the troubled drugmaker.
written on 20.05.2014
FDA nails Sun plant for same data deletions found at Ranbaxy
